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Abstract Size, weight and position are three of the most
important parameters that describe a molecule in a biological
system. Ion mobility spectrometry is capable of separating
molecules on the basis of their size or shape, whereas imaging
massspectrometryisaneffectivetooltomeasurethemolecular
weight and spatial distribution of molecules. Recent develop-
ments in both fields enabled the combination of the two
technologies. As a result, ion-mobility-based imaging mass
spectrometry is gaining more and more popularity as a (bio-)
analytical tool enabling the determination of the size, weight
andposition of severalmolecules simultaneously on biological
surfaces. This paper reviews the evolution of ion-mobility-
based imaging mass spectrometry and provides examples of its
application in analytical studies of biological surfaces.
Keywords Mass spectrometry.Ion chromatography.
Imaging.Genomics/proteomics
Introduction
Key questions in analytical biology and biochemistry
evolve around the determination of three basic molecular
properties: size, weight and position. The complex interplay
between molecules in living systems results in a continuous
alteration of these properties at the molecular level. The
need for analytical approaches that provide better insight
into these processes is growing, as understanding of these
systems is increasing. A cell, a tissue section, a tissue
extract or a body fluid contains a huge amount of chemical
and biological information. A single analytical method is
usually insufficient when a better understanding of the
function of these different biological systems is targeted.
This is caused by the complexity of these systems. For that
reason a combination of different instruments is extensively
used in biochemical research. Ion mobility spectrometry
(IMS) coupled with imaging mass spectrometry (MS) is
one of these combined approaches that have the potential to
provide direct insight into the shape, structure and position
of biomolecules. The combination of MS with IMS has
already proven to be an extremely successful technique for
determining the structures of ions in the gas phase as it
allows the separation of different structural isomers. The
addition of a molecular imaging component enhances the
molecular detail provided.
The basics of IMS have been known for a long time.
Rutherford [1] was one of the first researchers who
performed measurements based on the mobility of ions
when he measured the velocity of different gas ions. Still,
the first ion mobility spectrometers that enabled the
separation of ions on the basis of their physical collision
cross-section were built only in the 1960s. Ions were simply
forced to drift in a gas cell. The first ion mobility mass
spectrometers coupled with magnetic sector instruments
were also built in the 1960s [2], almost immediately after
the development of the first ion mobility spectrometers.
Since then the combination of ion mobility cells with both
continuous and pulsed ion sources has been solved and ion
mobility spectrometers have been coupled with many
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(TOF) analysers [3, 4] magnetic sector instruments [2],
quadrupoles [5, 6] ion traps [7–9] and Fourier transform ion
cyclotron resonance instruments [10–12]. The first ion
mobility instruments were pure drift-time instruments. Two
other types of ion mobility spectrometers evolved, differ-
ential mobility analysers (also called high-field asymmetric
ion mobility spectrometers) and recently travelling-wave
instruments.
Initially, ion mobility spectrometers were used only in
the field of physical chemistry and for plasma physics
research. The development of the matrix-assisted laser
desorption and ionization (MALDI) [13–15] and electro-
spray ionization (ESI) [16, 17] methods in the late 1980s
enabled the measurement of large biomolecules by MS.
This also resulted in a major breakthrough in the field of
ion mobility MS (IM-MS) in the 1990s. The first work
where the mobility of biomolecules was measured was
undertaken by Clemmer et al. [18]. In this publication, the
possibility of measuring the conformation of proteins with
IM-MS was demonstrated. The results led to the matura-
tion of the technique and since then IM-MS has been used
for structural studies of several different biomolecules,
such as proteins [18–20], lipids [21–26], carbohydrates
[27–30] and even intact viruses [31–33]. It was also shown
in several works that the separation of optical isomers is
possible using chiral modifiers in the collision gas [34–36].
The potential of using ion mobility mass spectrometers in
biological and biochemical research accelerated the
development of the instrumentation and moved the field
from custom-built instruments to commercially available
instruments. Nowadays, several vendors sell ion mobility
mass spectrometers and these instruments are becoming
more and more popular.
In parallel to the development of IM-MS, another
bioanalytical technology has emerged: imaging MS [37,
38]. Imaging MS is an MS technique where the spatial
distribution of different classes of molecules can be
determined on a surface. It is perceived as one of the
emerging tools in proteomics, lipidomics and metabolo-
mics. Recent developments in imaging MS allow the direct
detection of biomolecules as proteins, lipids and drugs on
tissue. Label-free imaging with MS uses an intrinsic
molecular parameter, the molecular mass, to identify and
visualize the distribution of a wide variety of biomolecules
at surfaces. This allows the combined determination of
molecular weight and localization. An imaging MS experi-
ment requires surface molecules to be desorbed and
ionized. Two general approaches can be distinguished in
imaging MS. The first and oldest approach uses energetic
charged particles to generate surface ions for mass analysis.
This approach is common to secondary ion MS (SIMS).
The second approach uses photons to generate surface ions
for mass analysis. This is the domain of laser-based MS
technologies such as MALDI. There is a continuous stream
of new desorption and ionization technologies that extend
the capabilities of imaging MS. Desorption ESI and laser
spray are examples of recently conceived ambient desorp-
tion and ionization methods that further the application
areas of imaging MS. The interested reader is referred to
recent imaging MS reviews [37, 38] for an overview of all
relevant innovation in desorption and ionization for imag-
ing MS. Here we will briefly introduce the key concepts of
SIMS and MALDI for imaging MS.
SIMS involves the analysis of secondary ions generated
from a surface when this surface is bombarded with
primary particles. These primary particles are typically
elemental ions generated from a liquid metal ion source.
The ‘sputtered’ secondary particles will be electrons,
neutrals and ions. These ions are amenable to analysis with
a mass spectrometer and provide insight into the chemical
composition of the surface. As a rule of thumb, with a
primary ion dose below 10
13 ions/cm
2, each individual
primary ion samples a fresh spot on the surface. This is
referred to as the ‘static limit’. An ion-induced modification
of the surface is sampled with a primary ion dose above this
static limit. Under these conditions the surface changes
rapidly and is sputtered with a fixed sputter rate. The
regime where the primary ion dose exceeds the static limit
is hence referred to as ‘dynamic SIMS’. Traditionally,
SIMS has been applied in the domain of surface physics
and solid-state physics. Over recent decades, SIMS has
developed more and more as an analytical tool for
biological materials such as cells and tissue. Abundant
lipids and small peptides can be studied from these surfaces
through the use of sample modification strategies [39] and
new elemental cluster ion sources (Aun
m+ and Bin
m+)[ 40].
SIMS is traditionally implemented on a TOF mass
spectrometer that ensures a sensitive and high-throughput
analysis.
MALDI is a versatile and effective method to desorb and
ionize polymers, small organic molecules, lipids and amino
acids but also especially biomolecules such as peptides,
proteins and oligonucleotides [14]. The basic experiment
involves irradiating the sample with a pulsed laser to
generate analyte ions from the surface. A matrix solution is
applied to the tissue sample to facilitate effective MALDI
analysis. These solutions are used for the extraction of the
analyte molecules from the tissue and to create analyte-
doped matrix crystals. During the analysis, the surface is
irradiated by a pulsed laser, thus inducing ablation of these
analyte-rich crystals, which results in cooperative motion of
the analyte and matrix ions into the vacuum. MALDI can
be applied directly for the analysis of biological surfaces
and tissue sections. This makes it a key technology for
imaging MS.
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for imaging MS. Several research groups are combining
these technologies to enable ion-mobility-based imaging
MS. This review describes the evolution of ion-mobility-
based imaging MS from a historical perspective to the
current state of the art. The developments described have
resulted in an innovative (bio-)analytical technology for the
analysis of complex surfaces. Ion-mobility-based imaging
MS enables the direct determination of three of the most
important parameters of molecules on the surface of
biological systems: size, weight and position.
Size: the basics of IMS
The main physical phenomenon behind all of the ion mobility
methods is the collision of the ions with neutral gas molecules
or atoms. The change in the speed of the ions due to the
collisions is influenced by the collision cross-section of the
ions. Thus, IMS separates the ions on the basis of their size,
conformation and charge state instead of their mass. This way
it provides complementary shape information when it is
coupled with MS. The time frame of an ion mobility
separation is in the millisecond range, which is significantly
slower than the average time it takes to acquire a mass
spectrum. This makes the coupling of the two methods easy
because for every ion-mobility-separated peak several mass
spectra can be measured. A given molecular class usually
follows a trend line when the ion mobility is plotted as the
functionofthem/zoftheions.ThisisillustratedinFig.1 with
the different trend lines for peptides and lipids. The various
ion mobility methods can be grouped on the basis of whether
their ion separation selectivity is based on spatial dispersion
such as in drift tubes or travelling-wave instruments or on
temporal dispersion such as in high-field asymmetric IMS
(FAIMS) instruments.
Drift-time IMS
The first and simplest design ion mobility spectrometers were
drift-tube instruments. In this type of spectrometer the ion
mobility cell consists of series of stacked-ring electrodes
(Fig. 2). With use of these electrodes a near-uniform electric
field is created along the axis of the cell. An important part
of the drift tube is the collision gas, which is mostly nitrogen,
helium or argon. During the measurement ion packets are
injected into the cell and the ions drift from one end of the
cell to the other in the electric field. During their drift they
collide with the particles of the collision gas. This way the
time that it takes the ions to travel through the cell is affected
by their average collision cross-section. This is the basic
principle behind ion mobility separation. In drift-time
spectrometers the field strength is usually chosen such that
the diffusion processes will be dominant. To achieve this, the
electric field should be low enough so the thermal energy the
ions obtain from the collisions with the buffer gas is larger
than the energy they obtain from the electric field. This is
called the ‘low-field limit’. In this case the velocity of the
ions is directly proportional to the electric field.
This is one of the main advantages of the drift-time ion
mobility methods because the proportionality constant, called
the ‘ion mobility constant’ is simply related to the collision
cross-section of the ions. This way the collision cross-sections
can be determined directly from the drift time using only the
experimental parameters with the following formula:
K ¼
3q
16N

2p
kT
 1=2 m þ M
mM
 1=2 1
4

;
where K is the ion mobility constant, which is directly
proportional to the electric field and the velocity of the ions,
q is the charge on the ion, N is the number density of the
buffer gas, k is Boltzmann’s constant, T is the absolute
temperature, m is the mass of the buffer gas, M is the mass
of the ion and Ω is the collision cross-section of the ion.
Drift-time ion mobility spectrometers can be either
Fig. 1 Matrix-assisted laser desorption and ionization (MALDI)–ion
mobility mass spectrometry (MS) conformation space obtained for a
mixture of model species representing each molecular class (ranging
from seven to 17 model species for each class, spanning a range of
masses up to 1,500 Da). Dashed lines are for visualization purposes,
where each molecular class occurs in conformation space. Signals in
the vicinity of the asterisk arise from limited post-ion-mobility
fragmentation of the parent ion species. (Reproduced with permission
from [41])
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ambient-pressure configuration provides better resolution
and greater separation selectivity, but because of the
inefficient transfer of the ions from the ion mobility cell
to the mass spectrometer such instruments suffer from
reduced sensitivity. Because of this, ambient-pressure
instruments are mostly used as standalone ion mobility
spectrometers for field analytical applications such as the
detection of explosives or dangerous chemicals at airports.
In addition to the ion transfer issues with the ambient-
pressure devices, both types of instruments suffer from the
need for narrow ion packets for the separation. This
seriously compromises their sensitivity, especially when
they are coupled to continuous ion sources. This problem
can be reduced using a trap cell preceding the drift tube that
traps the ions and releases them as narrow ion packets. Still,
with this ion accumulation the duty cycle of these instru-
ments is low. Thus, their sensitivity is lower than that of the
other type of instruments. Several attempts were made to
improve the ion transmission to the drift tube. These
include the use of various ion funnel designs [43] or the
use multiplex methods such as Fourier transform [44] and
Hadamard transform [45, 46] to deconvolve the signals
after the continuous introduction of ions into the ion
mobility cell instead of using ion packets and thus
improving the duty cycle of the instrument.
The other direction in which ion mobility spectrometers
have been improved is the resolution of the separation.
Several developments have recently been reported in this
field as well, such as the so-called ion cyclotron mobility
spectrometer developed by Clemmer and co-workers [47].
This device consists of four curved drift tubes and four ion
funnels in cyclotron geometry. In this configuration the
flight path of the ions in the drift tube can be increased
significantly since it depends on the number of cycles in the
spectrometer. There have been several developments to
overcome the sensitivity issues of the drift-time instru-
ments, such as overtone ion mobility spectrometers, another
recent development by Clemmer and co-workers [48, 49].
Their goal was to build a drift-tube instrument which
operates as a continuous ion mobility filter rather than using
the above-mentioned gating of ion packets that results in
decreased sensitivity. To achieve this they divided the linear
drift tube into multiple segmented regions and they created
two sawtooth voltage gradients by applying the electric
field to pairs of segments. The sawtooth voltage is offset by
one segment across the whole drift tube and the voltages
are alternated during the separation. This way the ion
transmission will be a function of the frequency, so an
intensity–frequency plot is used to visualize the measured
data. The interesting feature of the method is that a given
ion gives a signal not only at the fundamental frequency but
also at multiples of the fundamental frequency and usually
the resolution of these so-called overtone peaks is better
than that at the fundamental frequency.
It is possible to couple two drift cells and to do IMS
2
experiments [50–52]. In this case the ions are excited
between the two ion mobility cells, so their conformation
will be different. These types of experiments can provide
valuable information about the energetics of conformational
changes of gas-phase ions. This way the peak capacity of
the method can be further increased as well as making
possible the high-throughput analysis of proteins in
biological samples such as human plasma.
Travelling-wave IMS
Travelling-wave IMS is the youngest of the ion mobility
separation methods. The idea is based on a patent from
Fig. 2 A high-resolution drift-
time ion mobility mass
spectrometer. ESI electrospray
ionization, TOF time of
flight analyser. (Reproduced
with permission from [42])
2626 A. Kiss, R.M.A. Heeren1993 by Kirchner [53] but the first commercial instruments
were produced only in 2004 [54]. Travelling-wave IMS is
based on the use of stacked-ring ion guides (SRIGs) similar
to the configuration in drift-time instruments. In these
devices an opposite phase of RF is applied to consecutive
ring electrodes. The potential generated in one of these ion
guides can be seen in Fig. 3.
The main flaw of this design is that there are undulations in
the potential surface in the z direction where ions can be
trapped. This can significantly slow down the progress of the
ions through the ion guide or can even prevent their exiting the
cell. As a result, the ions need to be propelled through the ion
guide. In travelling-wave instruments a DC potential is super-
imposed on theRF of anelectrode whichis subsequently swept
over successive electrodes. This creates a moving electric field
called a ‘travelling wave’ [54]. The simulation of the ion
trajectories indicates that the ions roll down the potential
gradient, then the potential pulse moves forward and the
process is repeated (Fig. 3b). This way the ions are propelled
through the cell by the wave. For ion mobility separations one
of these ion guides is filled with a neutral gas, usually
nitrogen or argon. In this case the ions not only ‘surf’ on the
waves as described above but they also roll over the waves
owing to collisions with the gas particles. Low-mobility ions
roll over the waves more often than high-mobility ions; thus,
they leave the cell later, as can be seen in Fig. 3.
There is one commercially available instrument equipped
with a travelling-wave cell as shown in Fig. 4.T h i si s
essentially a quadrupole TOF instrument where the travelling-
wave ion mobility cell is located between the quadrupole and
the TOF analyser. The ion mobility cell consists of three
consecutive SRIGs. The first is called ‘the trap cell’, intended
to trap the ions and to release them in packets in the mobility
cell. In the second one the actual ion mobility separation
takes place. The third one is called ‘the transfer cell’ and its
role is to transfer mobility-separated ion packets to the TOF
analyser (Fig. 4). The advantages of this design are the
r e l a t i v e l yh i g hd u t yc y c l eb e c a u s eo ft h et r a pS R I Ga n dt h e
quadrupole analyser before the ion mobility cell, and the
possibility to enhance the detection of certain mobility-
separated ions by synchronizing the pusher of the TOF and
the release of the ions by the transfer cell. Also, these
Fig. 3 a Calculated effective
potential for a stacked-ring ion
guide (SRIG). b Series of
SIMION plots showing an ion
surfing on the front of a
travelling wave as it passes
along the SRIG. c Mobility
separation in the travelling-wave
ion guide. (Reproduced with
permission from [54])
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dissociation fragmentation before the ion mobility separation
in the trap cell or after the mobility separation in the transfer
region, which has the advantage that the fragments will have
the same drift time as the corresponding parent ions. It is also
possible to fragment the ions in both cells, which leads to
MS
3-like experiments.
The main issue with this type of instrument is the relatively
low resolution, although with recent developments it was
increased to around 40Ω/ΔΩ. This was achieved byincreasing
the length of the mobility region and adding an additional
region filled with helium before the mobility ion guide.
Another drawback of the method is the lack of a simple
relation between the drift times and the collision cross-
sections of the analytes. There have been recent attempts to
find the relation between these two parameters. Shvartsburg
and Smith [56] have proposed a physical model to describe
the properties of a travelling-wave cell that addresses this
issue. Despite these attempts, the experimental collision
cross-sections are still determined using different compounds
with known collision cross-sections as calibration standards
[57, 58]. Since this is the youngest of the three ion mobility
separation methods, it is expected that the above-mentioned
issues will be dramatically reduced in the future.
Differential mobility analysers
The idea of the method first appeared in a Soviet patent in
the 1980s [59] and was published in referenced literature in
1993 [60]. The mobility of ions depends on the ratio of the
electric field intensity and the gas number density. The
electric field density between two electrodes oscillates
between high and low field and the ions are separated on
the basis of their mobility difference in high and low field.
This is achieved by passing the ions between two parallel
electrodes through a carrier gas while on one electrode a
voltage waveform is applied. This causes an oscillation of
the ions. Their mobility difference between the high and
low field will force them to drift in the direction of an
electrode, where they will be neutralized. For each species a
given compensation voltage has to be applied to one
electrode to allow those ions to pass between the electrodes.
It is possible to scan with the compensation voltage over a
wide range of species with their respective mobility differ-
ences, which results in mobility spectrometry. Alternatively,
one compensation voltage can be set that enables the
exclusive transmission of ions with a specific mobility
difference, i.e. mobility filtering. This is why this type of
i o nm o b i l i t ya n a l y s e ri so f t e nc o n s i d e r e dt ob ea n a l o g o u st o
quadrupole mass analysers.
Mainly two electrode geometries are used: plate electrodes
(Fig. 5a) or electrodes with cylindrical geometry (Fig. 5b).
The latter design not only separates the ions on the basis of
their mobility but also focuses the ions and reduces ion loss
due to diffusion and Coulomb repulsion [63]. One concern
regarding this disadvantage of this design is the limited
resolution. This is a direct result from the wider compensa-
tion voltage range needed to keep the ions stable and
allowing them to pass the analyser. Although simulations
Fig. 4 The Waters SYNAPT ESI HDMS mass spectrometer equipped with a travelling-wave ion mobility cell. The abbreviation IMS refers to the
ion mobility separation device. (Reproduced with permission from [55])
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achieved with planar geometry [64], it is important to
improve the sensitivity of these instruments. One solution is
to use a slit aperture instead of the common circular orifice
between the ion mobility analyser and the mass spectrometer,
which will improve the ion transmission and refocus the ions
inthemassspectrometerinanelectrodynamicionfunnel[65].
One of the main advantages of the method is the size of the
instrument. Field asymmetric ion mobility spectrometers can
be produced with dimensions under a few centimetres without
seriously compromising the resolution of the instruments. This
makes these devices well suited for the production of portable
ionmobilityspectrometers.Oneofthepotential applicationsof
such instruments is the detection of explosives [66, 67].
Owing to their slightly differing principles, FAIMS and the
other ion mobility methods provide slightly different conforma-
tional information about the ions. Tandem ion mobility
separation becomes possible through the coupling of FAIMS
with another ion mobility method [68]. This is especially
advantageous as there are currently no means to extract
structural information from FAIMS results. A 2D-FAIMS/IMS
measurement will reveal the ion geometry separated by
FAIMS. Despite their low resolution, isomers or isobars are
often distinguished by FAIMS better than by conventional
IMS. This is because the differential mobility is much more
weakly correlated with the ion mass than the absolute mobility.
Two directions of development were made possible by the
miniaturization of the FAIMS analyser. One is increasing the
speed of the method by applying higher fields on the two
electrodes [69, 70]. The separation speed scales with the
fourth to sixth power of the electric field, so this way the
separation speed can be increased extensively (about 100–
10,000 times higher when the electric field intensity is
increased to over 60 kV/cm) although the resolution of these
devices is lower than that of the other designs. The other
method was proposed to increase the resolution of FAIMS
instruments [71, 72]. It has been known for a relatively long
time that using He/N2 mixtures in these instruments with as
high He content as possible can increase the resolution. A
typical planar high-field asymmetric IM spectrometer design
with a 2-mm gap between the two electrodes precludes the
use of gas mixtures with He content higher than 65%.
Electrical breakdown has been observed between the two
electrodes at higher He contents. Shvartsburg et al. [71, 72]
proved with a slightly modified instrument that He/N2 gas
mixtures up to 75% He content can be used without
observing electrical breakdown. This way the resolution of
the instruments can be increased to around 100, in line with
the resolution of common drift tubes.
Weight: IM-MS coupled with a MALDI ion source
Since its development in the late 1980s by Karas et al. [13–
15], MALDI-MS has become one of the main ionization
techniques used in the field of proteomics. The method has
Fig. 5 Planar geometry (a) and cylindrical geometry (b) high-field asymmetric ion mobility spectrometry (FAIMS) analysers and the ion motion
in a planar FAIMS device (c). (a Reproduced with permission from [61]; b and c reproduced with permission from [62])
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tolerance of salts. It mostly produces singly charged ions,
whereas during the electrospray process several multiply
charged species arise, making the mass spectra and also the
ion mobility spectra more complex. Because of the lack of
separation, usually ion suppression and significant chemical
noise such as matrix-related peaks can decrease the
sensitivity of the method. Combined with low-resolution
MS it is difficult to separate ions that are nominally isobaric.
Although it is possible to use off-line high-performance
liquidchromatography(HPLC)separationbeforeMALDI-MS
measurement, this solution has some disadvantages, mainly
the significantly increased measurement time needed to
analyse a sample. Most of these limitations can be overcome
or at least reduced when IM-MS is used with a MALDI ion
source. MALDI ion sources operate in pulsed mode, so they
are more easily coupled with ion mobility devices than are
electrospray ion sources. One of the first examples where a
MALDI ion source and IM-MS were coupled was the
instrument developed by the group of Bowers [73] in 1995.
They used a magnetic sector instrument equipped with a
MALDI ion source and they coupled a drift-time ion mobility
spectrometer after it. They used this instrument to study the
conformation of several polymer ions, namely sodiated poly
(ethylene glycol) ions. Since then several papers have been
published wherein it was reported that ion mobility mass
spectrometers were used to examine even biomolecules and
biological mixtures.
Koomenetal.[74] developed a method for rapid screening
of oligonucleotides. This work in 2002 was the first where
MALDI-IM-MS was used for the study of different
oligonucleotides. It was demonstrated that an ion mobility
cell with a mobility resolution of 20–30 is sufficient to
separate oligonucleotides of different length and to remove
the chemical noise caused by matrix signals. However, they
did not have enough resolution to separate different structural
isomers. The resolution of the ion mobility cells alone is also
not enough to separate oligonucleotides with the same length
but different mass; in this case the MS data have to be used
to differentiate between the species. Also, they studied the
separation of different DNA fragment ions and determined
chemical modifications of DNA using MALDI-IM-MS.
Their results suggest that MALDI-IM-MS can be used to
study chemically modified DNA oligonucleotides and DNA–
drug and DNA–metal complexes.
McLean and Russell [75] proved in a publication from
2003 that sub-femtomole amounts of peptides can be
detected using MALDI-IM-MS . They used a high-
repetition-rate laser to increase the duty cycle of the
instrument. Sub-femtomole amounts of angiotensin I and
angiotensin II and also a tryptic digest of bovine haemo-
globin were measured. This proved that using IM-MS with
a MALDI ion source will not decrease the detection
sensitivity significantly owing to the pulsed nature of the
ion source.
In 2004 Woods et al. [21] demonstrated that it is possible
to use MALDI-IM-MS for the separation of complex
biological mixtures. It was shown in this work that
peptides, lipids and oligonucleotides form distinct trend
lines which make possible the rapid separation of these
different compound classes. Also, MALDI-IM-MS was
used for the rapid screening of drugs in saliva.
One of the fields that can benefit tremendously from the
use of MALDI-IM-MS is proteomics [76]. One of the main
advantages of the method compared with classic HPLC-MS
workflows is its speed. The liquid chromatography separa-
tion of complex biological mixtures can take from several
minutes to hours, whereas ion mobility separation takes
only milliseconds. There are several proteomics experi-
ments where IM-MS can be effectively used, such as
increasing the confidence of protein identification by
separating isobaric tryptic peptides. In conventional experi-
ments to determine post-translational modifications the
interpretation of the mass spectra can be difficult because
of neutral losses and the small concentration of the
modified protein. Some simulations suggest that, for
example, phosphorylation changes the protein conforma-
tion, leading to a more compact structure, which can thus
be beneficial for the study of such modifications by IM-
MS; thus, IM-MS is potentially a powerful tool to study
post-translational modifications and protein–small molecule
complexes. IM-MS also provides a means to study the
conformation of gas-phase ions and with variable-
temperature ion mobility separation protein folding and
unfolding processes, which can be important to understand
diseases that are related to protein misfolding such as
Parkinson’s or Alzheimer’s disease. Another technique that
can benefit from IM-MS is imaging MS. This technique
will be discussed in detail in the next section.
In a recent paper McLean’s group [77] reported a
custom-built drift-time instrument with interchangeable
MALDI and nano-ESI sources and evaluated the instrument
for comparison of the mobility of ions produced by ESI and
MALDI processes. These experiments can be beneficial to
better understand how the conformation of the ions will
change during the ionization process in different ion
sources. This information is crucial for biochemical studies
where the conformation of biomolecules is investigated by
IM-MS.
Position: IM-MS in imaging experiments
Imaging MS emerged in recent years as a powerful
discovery tool for biochemical studies. However, the
performance of the technique is compromised by the
2630 A. Kiss, R.M.A. Heerencomplexity of the sample. This can cause ion suppression
and also several nominally isobaric species can be present
that cannot be resolved using TOF analysers. Recently, it
was demonstrated that this can be improved using a Fourier
transform ion cyclotron resonance mass spectrometer, an
instrument which has mass resolution far superior to that of
TOF instruments [78]. Another solution is the use of a
separation technique, but because of the nature of the
samples, chromatographic techniques cannot be used. An
effective way to solve this problem is to add a separation
step after the ionization; thus, the use of IM-MS can
address some of the aforementioned limitations. With IMS
it is possible to separate isobaric species, although it will
not prevent ion suppression because the separation takes
place after the ionization process. Another useful property
of the method is the possibility to remove chemical noise
such as matrix-related peaks, this way simplifying the
interpretation of the spectra and also improving the contrast
of the ion images.
Lipids are one of the most abundant biomolecules in
tissue sections. They also ionize easily; thus, they can be
easily studied by imaging MS. They can also be associated
with several diseases, so they are interesting also from a
medical point of view. The imaging of lipids can benefit
from ion mobility separations since different classes and
structures of possible isobaric species exist. It is not
surprising that there are several published reports of the
study of the distribution of lipids, especially phospholipids,
using ion mobility separation before the mass-spectrometric
detection. One work was by Jackson et al. [23] and another
was by McLean’s group [79], both from 2007, where the
possibility and usefulness of using ion mobility separation
for the imaging of different lipid classes, mainly phospho-
lipids from brain samples, were demonstrated.
One of the main advantages of imaging MS is the
capability to measure the distribution of drugs and their
metabolites selectively and simultaneously in whole-body
sections without using labelling [80, 81], thus giving
information complementary to that obtained from conven-
tional whole-body autoradiography measurements. Trim et
al. [82] investigated whether the coupling of ion mobility
separation with imaging MS has additional benefits for
pharmaceutical studies. The distribution of vinblastine and
its metabolites was studied in mouse whole-body sections
using ion mobility imaging MS and MS/MS. An endoge-
nous lipid isobaric to vinblastine and also one isobaric to
one of its metabolites were observed. Removing these
isobaric backgrounds by ion mobility separation alters the
spatial distribution of the mass related to vinblastine or its
metabolite and increases the confidence in the results
(Fig. 6).
In 2010 Ridenour et al. [24] described a method to
determine the collision cross-section of phospholipids and
tryptic peptides directly from tissue using MALDI-T-wave-
IM-MS data. It was indicated that it is important to calibrate
the instrument with the same class of compounds. They
observed that if the instrument was calibrated with the drift-
timecollisioncross-sectionvaluesofpeptidesforphospholipid
measurement, then the average difference between the drift-
time and the T-wave collision cross-section values was 7%,
whereas with phospholipid drift-time data this value can be
decreased below 0.5%.
Recently, the use of MALDI-IM-MS was reported for
on-tissue bottom-up proteomics experiments using
formalin-fixed, paraffin-embedded (FFPE) tissue samples
in several papers. FFPE samples are amongst the most
challenging samples. However, formalin fixing and parafin
embedding is the standard protocol that pathologists use to
fix tissue sections for storage and these samples are
available in great numbers for the study of different
diseases. One of the problems is that FFPE samples require
extensive washing with different solvents to remove the
paraffin, but this can easily damage the sample. The
formalin fixing cross-links the proteins, so enzymatic
digestion is necessary to study these tissue sections.
In one report, a 78-kDa protein called glucose-regulated
protein 78 kDa (Grp78) was identified from pancreatic
adenocarcinoma tissue after tryptic digestion. The spatial
distribution of the tryptic peptides related to Grp78
suggested high expression of the protein in the adenocar-
cinoma cells [83]. This result demonstrates that the use of
MALDI-IM-MS imaging allows the localization of a
tumour biomarker in on-tissue-digested FFPE samples.
In other work, FFPE rat brain and frozen human brain
samples were analysed after on-tissue digestion of the
proteins [84]. It was shown that with the additional ion
mobility separation the number of detected peaks increased
owing to the separation of isobaric species. Also the
improved confidence of protein identification was proved
when ion mobility separation is used. Tubulin and ubiquitin
have isobaric tryptic peptides at 1,039 m/z that have
different spatial distributions in the brain (Fig. 7). If an
MS/MS experiment without ion mobility separation is
performed, the resulting spectrum will contain a mixture
of fragment peaks from the fragmentation of both species.
MASCOT identification of the proteins is severely ham-
pered by this phenomenon. Imaging experiments without
ion mobility result in an average image of the two proteins.
With drift-time separation the fragmentation products of the
two peptides are separated, thus providing higher scores for
a MASCOT search and increasing the confidence of the
identification of the proteins. It reveals different spatial
organization of the proteins.
Also, recent work by Djidja et al. [85] used imaging
combined with ion mobility separation for tumour classifi-
cation. The samples studied were pancreatic cancer tissue
Size, weight and position: ion mobility and imaging MS combined 2631microarray (TMA) samples and human FFPE tissue
sections. After tryptic digestion of the TMA samples,
MALDI-IM-MS, MALDI-IM-MS/MS and principal com-
ponent analysis–discriminant analysis (PCA-DA) were
employed to generate tumour classification models. It was
found that the use of IM-MS is beneficial for similar studies
as it provides the exact distribution of proteins as a result of
minimization of peak interferences. This also results in
better protein identification from database searches. The
classification model they built up was verified after
statistical analysis of the TMA results by measuring the
digested FFPE tissue sections with MALDI-IM-MS. The
distribution of characteristic peptides of the tumour region
highlighted by the PCA-DAwas in good agreement with the
histological data, thus confirming the PCA-DA statistical
method.
Summary and outlook
The importance of IM-MS has increased during the past
decade and most likely this trend will continue. The
separation speed obtainable, the possibility to acquire
additional information about the structure of different
molecular classes and the easy coupling with MS contrib-
utes to the maturation of this technique. We have described
Fig. 6 Comparison of a m/z
811 and b m/z 811-751 images
obtained using MALDI–ion
mobility spectrometry (IMS)–
MS/MS and conventional
MALDI-MS/MS. These images
clearly demonstrate the advan-
tages of ion mobility separation
within MALDI xenobiotic
imaging. The main difference
observed is indicated: the
distribution of the ions of inter-
est within the renal pelvis. c
whole-body autoradiograph
showing the distribution of
3H
in a 1-h postdose rat dosed with
6 mg/kg
3H-vinblastine intrave-
nously, confirming the distribu-
tion observed with MALDI-
IMS-MS/MS. (Reproduced with
permission from [82])
Fig. 7 Images of separated and identified isobaric ions of tubulin and
ubiquitin peptide fragments (1,039 m/z) are presented directly on
tissue by ion mobility MS imaging (BioMap). For these images, two
different drift times were selected: 100–127 and 133–148 bins to
reconstruct the respective images. Without any ion mobility, one
image is obtained corresponding to the superposition of these two
images. (Reproduced with permission from [84])
2632 A. Kiss, R.M.A. Heerensome of the technological developments that have contrib-
uted to the growing importance of IM-MS. Several research
areas have been described that can benefit from the use of
IM-MS. These examples also demonstrate the utility of IM-
MS to address the need for additional separation steps in
imaging and MALDI proteomics applications. Another
possible utilization of imaging IM-MS is in the field of
quantitative imaging. Quantitation of molecules on tissue is
seriously hampered by ion suppression and nominally
isobaric species present. With use of ion mobility separa-
tion the precision of the quantitation can be increased
through the removal of the nominally isobaric ions. This
approach has great potential in future quantitative molecular
imaging experiments using MS.
As we showed IM-MS has several limitations, such as
the significantly decreased sensitivity that needs to be
overcome to study low-abundance species with IM-MS.
There is a strong need to further increase the resolution of
the existing IM-MS methods to obtain more structural
separation. Most of the current instrumental developments
aim at improving these areas.
Besides the instrumental developments, we expect better
understanding of the connection between ion drift times and
collision cross-sections, especially in the case of the T-wave
[56] and FAIMS [86] devices. There is growing interest in
predicting the collision cross-sections of peptides on the
basis of their sequence [87]. In the future, developments in
bioinformatics may also help to handle the increased
datasets resulting from the use of ion mobility separation
as an additional dimension in the data.
It was shown that the combination of IMS and imaging
MS is capable of determining the size, weight and position
of biomolecules simultaneously from complex samples,
rendering it an essential tool in the field of analytical
biochemistry.
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